Skip to main content

Interpace Biosciences, Inc.

IDXG
Exchange
OTC
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001054102

No open-market purchases or sales by Interpace Biosciences, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesIDXGD

Q2 2021 vs. Q1 2021

How the institutions holding Interpace Biosciences, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of IDXG: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders30−3
Shares12.3K0−12.3K (−100.0%)
Value$58.0K$0−$58.0K (−100.0%)

New holders (0)

Institutions that held Interpace Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

None.

Sold out (3)

Institutions that held Interpace Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of IDXG in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
HRT Financial LP11,145$52.0K
Retirement Group, LLC1,000$5.00K
Tower Research Capital LLC (TRC)177$1.00K